Stomach cancer screening plays an important role in identifying early changes in the stomach lining before symptoms become severe. In Singapore, screening is especially relevant for individuals with risk factors such as a family history of gastric cancer, long-term Helicobacter pylori infection, chronic gastric inflammation, or persistent upper gastrointestinal symptoms.
Many patients feel uncertain about what the screening process involves. Understanding what happens before, during, and after screening can help reduce anxiety and support informed decision-making.
In this article, we explain what patients can expect from stomach cancer screening, the tests commonly used, and how results guide follow-up care and staging if abnormalities are found.
Why Stomach Cancer Screening Matters in Singapore
Stomach cancer often develops gradually, with early-stage disease producing few or no symptoms. When symptoms such as unexplained weight loss, persistent indigestion, vomiting, or anaemia appear, the disease may already be more advanced.
Screening allows doctors to identify abnormalities early, when treatment options are broader and outcomes are generally more favourable. Early detection also helps reduce complications and provides clarity on whether further investigations are necessary.
In Singapore, screening is typically recommended for individuals who:
- Are over the age of 40 with persistent gastric symptoms
- Have a family history of gastric malignancy
- Have a history of gastric ulcers or chronic gastritis
- Are known to have H. pylori infection
Stomach Cancer Screening: Tests Commonly Used
GastroClear Blood Test
In selected individuals, a blood-based risk assessment test such as GastroClear may be considered as part of stomach cancer awareness and screening discussions.
GastroClear is a Singapore-developed blood test that evaluates specific biomarkers associated with gastric cancer risk. It is designed to identify individuals who may benefit from further diagnostic evaluation, particularly those with risk factors such as long-standing Helicobacter pylori infection, a family history of gastric cancer, or persistent upper gastrointestinal symptoms.
As a blood test, it is generally safe and minimally invasive, making it a convenient option in initial risk assessment. However, it does not replace diagnostic procedures such as upper gastrointestinal endoscopy. If results suggest increased risk, endoscopic evaluation may be recommended for direct visual assessment and biopsy where necessary.
By supporting risk stratification, this approach may help guide timely discussions on further investigation.
Upper Gastrointestinal Endoscopy
Upper gastrointestinal endoscopy is the primary test used for stomach cancer screening. During this procedure, a thin, flexible tube with a camera is gently passed through the mouth into the stomach. This allows our specialist to examine the stomach lining directly for ulcers, abnormal tissue, or early cancerous changes.
If suspicious areas are seen, small tissue samples (biopsies) may be taken for laboratory analysis. The procedure is usually performed under sedation to improve comfort and typically takes less than 20 minutes.
Biopsy and Histological Examination
Biopsy samples collected during endoscopy are examined under a microscope. This step confirms whether abnormal cells are present and whether they are benign, pre-cancerous, or malignant.
Biopsy results are essential in determining the presence of stomach cancer and guiding the next steps in care.
Imaging Tests (If Required)
If abnormalities are detected, imaging studies such as CT scans or ultrasound may be used to assess whether the condition has spread beyond the stomach. These tests help evaluate lymph nodes and surrounding organs, contributing to staging decisions.
Preparing for Your Screening Appointment
Before stomach cancer screening, patients are typically advised to fast for at least six hours. This ensures clear visualisation of the stomach lining during endoscopy.
Our team will review your medical history, current medications, and any previous gastrointestinal conditions. Patients taking blood-thinning medications may receive specific instructions before the procedure.
It is also important to inform the care team of any allergies, previous reactions to sedation, or chronic medical conditions.
What Happens During the Screening Procedure
On the day of screening, patients are monitored throughout the procedure. Sedation is commonly used to help patients remain comfortable and relaxed.
During endoscopy:
- The scope is gently inserted through the mouth
- The stomach lining is examined in real time
- Biopsies may be taken if abnormalities are found
Most patients do not recall the procedure and experience minimal discomfort afterward.
After Screening: Recovery and Results
After the procedure, patients rest briefly until the effects of sedation wear off. Mild discomfort or bloating may occur but usually resolves within a day.
Initial findings may be discussed on the same day, while biopsy results typically take several days. Follow-up appointments allow us to review results in detail and discuss whether further tests or monitoring are required.
If stomach cancer is diagnosed, the results help determine stomach cancer stages, which guide treatment planning and follow-up care.
Understanding Staging and Outcomes
If stomach cancer is detected, doctors use the TNM staging system to describe how far the disease has progressed. This system assesses the size and depth of the tumour (T), whether lymph nodes are involved (N), and whether the cancer has spread to other parts of the body (M). Based on these findings, the cancer is grouped into Stage 0 to Stage IV, which helps guide care planning and follow-up.
- Stage 0 (carcinoma in situ): Abnormal cells are found only in the stomach’s inner lining (mucosa). These cells have not invaded deeper layers but may progress if untreated.
- Stage I: Cancer is limited to the stomach lining or muscle layer and may involve a small number of nearby lymph nodes.
- Stage II: Cancer has grown deeper into the stomach wall and/or spread to a greater number of nearby lymph nodes.
- Stage III: Cancer has extended through the stomach wall and may involve multiple lymph nodes or nearby organs.
- Stage IV: Cancer has spread to distant organs such as the liver, lungs, or distant lymph nodes. This is also referred to as metastatic stomach cancer.
Staging helps doctors discuss prognosis, including the stomach cancer survival rate, which varies depending on how early the disease is detected and individual patient factors. Early detection through screening is closely associated with improved outcomes.
Screening as Part of Preventive Digestive Care
Stomach cancer screening may be recommended as part of broader cancer screening in Singapore, particularly for individuals with ongoing gastrointestinal symptoms or elevated risk profiles.
Regular screening supports timely diagnosis and allows conditions to be managed before complications develop.
When to Speak to a Gastroenterologist
If you are experiencing ongoing stomach discomfort, unexplained weight loss, or have concerns about gastric cancer risk, screening may be appropriate. At Alpha Digestive and Liver Centre, our gastroenterologist, Dr Benjamin Yip, provides assessment and guidance on whether screening is suitable based on individual risk factors.
To learn more about stomach cancer screening or to arrange a consultation, you may contact Alpha Digestive and Liver Centre to discuss your concerns and screening options with our care team.
Summary: What to Expect from Stomach Cancer Screening
- Screening is often recommended for individuals with risk factors or persistent gastric symptoms
- Upper gastrointestinal endoscopy is the main screening test
- Biopsies help confirm diagnosis and guide staging
- Most procedures are done under sedation and are well tolerated
- Early detection supports clearer treatment planning and improved outcomes
References
- Stages of stomach cancer. Cancer.gov. https://www.cancer.gov/types/stomach/stages. Published May 31, 2023.
- Stomach cancer diagnosis and tests. Cancer.gov. https://www.cancer.gov/types/stomach/diagnosis. Published May 31, 2023.
